Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ZOR | Ann: E MAP Test | 07:05 | 0 | 40 | |||
|
|||||||
ZOR | Ann: End of Day | 17/04/24 | 0 | 79 | |||
|
|||||||
ZOR | Ann: E MAP Test | 17/04/24 | 0 | 99 | |||
|
|||||||
ZOR | Ann: End of Day | 16/04/24 | 0 | 71 | |||
|
|||||||
ZOR | Ann: E MAP Test | 16/04/24 | 0 | 118 | |||
|
|||||||
ZOR | Ann: End of Day | 15/04/24 | 0 | 76 | |||
|
|||||||
ZOR | Ann: E MAP Test | 15/04/24 | 0 | 142 | |||
|
|||||||
ZOR | Ann: End of Day | 12/04/24 | 0 | 130 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |